По данным статистики за третий квартал, потребительский спрос показал значительный оптимизм, и на этой неделе, в завершение сезона корпоративной отчетности, в фокусе рынка окажутся отчеты ритейлеров.

На фоне падения цен на нефть квартальные показатели Уверенности потребителей оказались на максимальных за последние семь лет значениях, что наверняка обеспечит значительный рост прибыльности ритейлеров.

На этой неделе отчитаются 2 компании, входящих в индекс Dow Jones – Cisco Systems в среду, и Wal-Mart Stores в четверг. Из значимых компаний также следует выделить:

Понедельник, 10 ноября – Rackspace Hosting (RAX), Sotheby’s (BID).

Вторник, 11 ноября — Fossil Group Inc. (FOSL), D.R. Horton Inc. (DHI), Beazer Homes USA Inc. (BZH), J.C. Penney Co. (JCP).

Среда, 12 ноября — Cisco (CSCO), Macy’s Inc. (M), Rockwell Automation (ROK), NetApp Inc. (NTAP), ADT Corp. (ADT).

Четверг, 13 ноября — Wal-Mart (WMT), Nordstrom Inc. (JWN), Kohl’s Corp. (KSS), Viacom Inc. (VIA), Applied Materials Inc. (AMAT), Tyco International Ltd. (TYC).

Из макроэкономических новостей можно выделить Отчеты по безработице в четверг, и данные розничных продаж, и Потребительского доверия в пятницу.

MIG International — надежный партнер на рынке ценных бумаг
 

Компания МИГ Инвест предлагает вашему вниманию новую торговую систему MACD RSI. Данная торговая система основана на range bars, индикаторах MACD and RSI.
Торговая система разработана трейдерами нашей компании, проста и удобна в использовании.
Вы можете ознакомиться с самой торговой системой MACD RSI, а также с комментариями к этой торговой системе.

Ближайший уровень поддержки по SPY – 204.00 уровень сопротивления – 204.25



AGIO продажа от 82, выше покупка

CHTR смотрим на покупку

TWC покупка выше 137

RYN смотрим на продажу

Новостные акции:
RAX, QIWI, ANIK, IMAX, RIO, VALE, BABA

Ближайший уровень поддержки по SPY – 201.00 уровень сопротивления – 202.50



CVX смотрим на продажу ниже 100

HLF покупка выше 48

AMBA продажа от 48

BABA отчет

WDC продажа от 101

AVB покупка выше 158

LH смотрим на откат вверх

CME покупка выше 85

Оригинал статьи: gtstocks.com/analytics-04-11-2014.html

Ближайший уровень поддержки по SPY – 193.50 уровень сопротивления – 195.00



NLNK выше 41 покупка, ниже продажа

IRB ниже 36,50 продажа

DUST смотрим на покупку

TLLP покупка выше 58

ASPS смотрим на откат вверх

Gapping up/down: NOK +9%, CAT +4% and GM +2% after earnings, BABA +1% after initiation at Overweight; YELP -12%, CAB -10%, CTXS -6% and UA -4% after earnings Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: JAKK +16.2%, EGHT +13.4%, SCSS +13.3%, TSCO +12.6%, INFN +12.6%, DAN +9.8%, NOK +8.7%, ACTG +8.3%, LCI +7.3%, PLCM +6.2%, LOGI +5.7%, YNDX +5.2%, JNS +5.2%, MKTO +4.5%, DO +4.4%, CAT +4.4%, ORAN +4.2%, SLM +4%, ORLY +3.9%, MLNX +3.5%, SHLM +3.3%, (following late move lower), ALXN +3%, FTNT +2.9%, LUV +2.7%, MMM +2.2%, NXPI +2.1%, SFG +2%, CSH +2%, BBW +2%, UNP +1.9%, NOW +1.8%, GM +1.7%, DMRC +1.6%, AB +1.6%, JBLU +1.5%, SGMO +1.4%, ORRF +1.3%, CAM +1.2%, RTN +1.1%, CMCSA +1%, CHKP +0.9%

M&A news: BRP +21.3% (Brookfield Asset Mgmt proposes to acquire 30% of Brookfield Residential Properties (BRP) not currently owned for $23.00/share), WWAV +7.2% (WhiteWave Foods or Boulder Brands (BDBD) may be possible takeover targets, according to Bloomberg real M&A column), PETM +3.1% (has received takeover interest from KKR (KKR) and outer PE firms, according to reports)

Other news: CYTX +50% (received FDA approval to resume ATHENA trial enrollment), VIMC +8.4% (announces $29.2 million contract win in Chenzhou city of Hunan province), KNDI +5% (still checking), PH +4.5% (increases quarterly dividend 31 percent and authorizes the repurchase of up to 35 million shares), RGLS +3.3% (after doubling yesterday), ERIC +3% (in symp with NOK), GPRO +2.9% (still checking), ING +2.1% (in symp with CS), BBRY +2.1% (trading higher, may be on NOK earnings, but also a story that co is unlikely to be acquired by Lenovo (LNVGY), according to reports), CSH +2% (approved the spin-off of its E-Commerce Division, Enova International, Inc., into an independent and separate publicly traded company), STX +1.7% (raises targeted annual dividend), UBS +1.7% (in symp with CS), CPXX +1.7% (pricing of a $12.9 million public offering of common stock at $1.95/unit and warrants to purchase common stock at $3.58/whole share and will have a term of five years), TWTR +1.5% (presented at Mobile Developer conf yday), V +1.3% (declared a quarterly dividend in the aggregate amount of $0.48 per share, a 20% increase), TSLA +1.2% (to enter Australia market, accoridng to reports), KMX +1% (raises share repurchase authorization by $2 bln), LYG +0.8% (plans to eliminate 9000 jobs, according to reports)

Analyst comments: ALU +6% (upgraded to Hold from Underperform at Jefferies), LUX +2.3% (upgraded to Buy from Hold at Berenberg), DOW +2% (upgraded to Buy from Hold at Deutsche Bank), BABA +1.1% (initiated with an Overweight at Barclays), ABBV +1% (resumed with a Overweight at JP Morgan), GSK +0.9% (upgraded to Overweight from Equal Weight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: AIRM -24.3%, YELP -12.5%, CAB -9.6%, CLB -6.8%, CTXS -6.6%, IPCM -6.2%, AWH -4.7%, (light volume), CAKE -4.5%, VAR -4.3%, ACAT -4%, UA -4%, OTEX -3.9%, DNKN -3.8%, TER -2.2%, SUSQ -2.1%, UN -1.9%, GOL -1.7%, LRCX -1.5%, WFT -1.5%, CA -1.3%, T -1%, PCP -1%, CCE -0.8%

Other news: ADHD -14.1% ( released a presentation with updated clinical trial results of Metadoxine Extended Release for the treatment of ADHD), FREE -9.1% (filed for 17,500,000 shares common stock, offering by selling stockholder), PT -5.4% (still checking), NMFC -3.8% (commences offering of 5,000,000 shares of common stock), WYY -3.7% (prices public offering of 6,896,552 shares of common stock at $1.45/share), ZAZA -1% (following 40% move higher yesterday), ISNS -0.9% (following 30% move higher yesterday), SPEX -0.8% (provides litigation update)

Analyst comments: MDCO -1.5% (downgraded to Neutral from Buy at BofA/Merrill)

Оригинал статьи: gtstocks.com/analytics-23-10-2014.html

Ближайший уровень поддержки по SPY – 190.50 уровень сопротивления – 192.25



SHLD продажа от 35

TSO продажа от 66

SOXL покупка выше 85

AAP смотрим на продажу

Gapping up/down: ILMN +9%, HOG +8%, TXN and AAPL +2% after earnings, PANW +1.5% after target raise; HAL +1% after upgrade; RMBS, -7%, ARMH -6%, KO -3% and MCD -2% after earnings, IBM -1% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: LXK +11%, ILMN +8.8%, HOG +7.8%, WERN +4.6%, CE +4.1%, CSL +3.7%, HLX +3.6%, WAT +2.5%, TXN +2.4%, AAPL +2.3%, AOS +2.3%, MBCN +2.2%, UTX +2%, STLD +1.9%, CDNS +1.1%, TRV +1.1%, ELS +0.9%, KMB +0.9%, CP +0.8%

M&A news: ACT +1.5% (Actavis and Sanofi (SNY) may be among bidders for Omega Pharma, according to reports).

Select EU financial related names showing strength: LYG +2.7%, RBS +2.5%, ING +2.3%, DB +0.8%.

Select metals/mining stocks trading higher: X 2.3%, MT 1.8%, AG 1.5%, GFI -0.5%.

Select oil/gas related names showing strength: STO +2.7%, SDRL +2.6%, BP +1.6%

Other news: NEON +22% (signs technology development agreement with global tier one printer OEM ), SGYP +13.1% (presents positive Phase 2b study results for Plecanatide in patients with irritable bowel syndrome), SCOK +5.6% (cont momentum), NXPI +2.6% (following TXN / AAPL results), GSAT +2.6% (co reiterated value of its spectrum assets; believes Kerrisdale continues to 'distort facts in attempt to undermine the benefits of TLPS'), TKMR +2.4% (cont momentum), CRUS +2.2% (following AAPL results), ABBV +2% (announced new $5 bln stock repurchase and increases dividend), BRCM +1.9% (following TXN results), RCL +1.9% (cont strength following yday's advance), TSL +1.7% (still checking), RFMD +1.5% (following AAPL results — component supplier), ACT +1.5% (Actavis and Sanofi (SNY) may be among bidders for Omega Pharma, according to reports), MU +1.4% (following TXN results), SUNE +1.4% (still checking), CCL +1.3% (cont strength following yday's advance), MGM +1.3% (still checking), MPW +1% (announced more than $1 billion in new real estate investments; expected to be accretive to normalized FFO by $0.09 — $0.12 per share), JEC +1% (awarded remediation task order for Eielson Air Force Base, Alaska worth ~$18.7 mln)

Analyst comments: POST +3.2% (upgraded to Buy from Neutral at Goldman), KITE +1.7% (target raised to $45 at Stifel), PANW +1.5% (target raised to $115 at Oppenheimer), COG +1.2% (upgraded to Outperform from Mkt Perform at Bernstein), HAL +1.2% (upgraded to Buy from Neutral at Guggenheim), EOG +0.5% (upgraded to Buy from Neutral at Guggenheim)

Gapping down
In reaction to disappointing earnings/guidance: GLF -8%, RMBS -6.9%, KALU -6.8%, UCTT -6.3%, ARMH -5.9%, APOL -5.4%, CMG -5.2%, XRS -3.3%, KO -3.1%, PKG -2.5%, CYS -1.6%, RCII -1.6%, LMT -1.6%, MCD -1.5%, IHG -1%, ZION -0.9%, BRO -0.9%, VZ -0.8%,.

Select Brazil related names showing weakness: OIBR -8.2%, PBR -7.7% SID -3.5%, VIV -2.8%, ELP -2.5%, GGB -2.2%, SBS -2.1%, VALE -1.7%, ABEV -1.4%.

Other news: RNO -42.8% (announces Q3 distribution of $0.05 per unit, lowered from previous quarter distribution of $0.445 per unit; co redoubling its cost cutting efforts due to weak coal markets), IBIO -20.2% (cont volatility), CVM -17.6% (announces proposed public offering of Common Stock; terms not disclosed), OMER -15% (provides update on PDE10 inhibitor program; enrollment in Huntington's Trial suspended pending further assessment of preclinical data), PT -8.3% (still checking, but Oi SA announces liquidation of assets will have no impact on the business combination with Portugal Telecom), LAKE -2.9% (cont weakness), TLLP -2% (prices upsized public offering of 20 mln common units at $57.47 per unit), SPLS -1.8% (spokesman has indicated company is investigating possible data breach, according to reports), ENTA -1.7% (provides update on its collaboration agreement with AbbVie (ABBV); co-development option on next-generation Protease Inhibitor ABT-493 Not Exercised, net sales allocations for ABT-450-containing regimens finalized), PHG -1.7% (cont weakness), REN -1.4% (provides operation update: Three Permian Basin horizontal wells averaged 1,300 Boe per day on peak 24-hour IP tests), GSK -1.3% (still checking), TRN -1.2% (late sell-off on guardrails ruling; confirms $175 mln in damages at jury trial)

Analyst comments: PHG -1.7% (downgraded to Neutral from Buy at UBS), IBM -0.7% (downgraded to Hold from Buy at Evercore; target lowered to $170 at RBC Capital Mkts), IRC -0.6% (downgraded to Underperform from Neutral at BofA/Merrill), ED -0.4% (downgraded to Underweight at Morgan Stanley)

Оригинал статьи: gtstocks.com/analytics-21-10-2014.html

Ближайший уровень поддержки по SPY – 187.00 уровень сопротивления – 188.50



BPL продажа ниже 73,50

PPC смотрим на откат вверх

Gapping up/down: MS and GE +4% after earnings, NVS +2% after NICE draft guidance, AKS and SUNE +6% after upgrades; URBN -13%, SNDK -3% and GOOG -1% after earnings Price: null Change: null

Gapping up
Briefing note: With S&P futures up over 1% in the pre-market, many stocks are gapping higher that are not listed.

In reaction to strong earnings/guidance: QLGC +10.1%, (also Announces Approval of a $100 million Stock Repurchase Program), FHN +6.1%, XLNX +5.7%, CPHD +4.1%, MS +3.8%, GE +3.7%, WDFC +3%, SLB +2.6%, HON +1.9%

M&A news: HZNP +1.9% (announces acquisition of U.S. rights to PENNSAID 2% From Nuvo Research Inc. for $45 mln in cash), EXP +1.8% (to acquire CRS Proppants for ~$225 mln)

Select EU related names showing strength: ING +3.3%, ALU +3%, ASML +2.3%, CS +1.8%

Select Ebola related stocks trading higher: IBIO +11.6%, NLNK +5.1%, LAKE +4.9%

Select oil/gas related names showing strength: PBR +4.1%, STO +3.3%, SDRL +2.9%, HAL +2.2%

Select fan favorites trading higher: GPRO +4.6%, TSLA +2.2%, TWTR +2.1%, AAPL +1.3%

Other news: AMPE +16.3% (announces results of the open label portion of the multiple intra-articular injections study of Ampion), SRPT +9.7% (announces publication of Ebola and Marburg Phase I Clinical Study results in antimicrobial agents and chemotherapy), FMI +9.1% (announced an agreement to enhance precision medicine options for Priority Health members with advanced cancers, also upgraded to Outperform from Mkt Perform at William Blair), BEAT +7.8% (announces reinstatement of Cigna's coverage of Mobile Cardiac Monitoring Services), HCLP +6.1% (announced 9% increase in third quarter 2014 distribution to $0.625 per unit), PPC +2.9% (following weakness in poultry names on SAFM Investor Day comments), NVS +1.9% (NICE has issued final draft guidance proposing to recommend imatinib, also known as Glivec and made by NVS ), X +1.8% (may be in symp with AKS upgrade),.

Analyst comments: AKS +6.1% (upgraded to Buy from Neutral at Nomura), SUNE +5.7% (upgraded to Outperform from Mkt Perform at Cowen), EJ +5.6% (upgraded to Buy from Neutral at Goldman), NBR +2.2% (upgraded to Buy from Neutral at UBS), GS +1.5% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), ISRG +0.9% (upgraded to Outperform at Leerink Partners)

Gapping down
In reaction to disappointing earnings/guidance: URBN -13.6%, (reports Q3 negative comparable retail segment net sale has continued quarter-to-date; gross profit margin may deleverage at a rate greater than during 1H), SNDK -2.8%, ATHN -2%, AMD -1.1%, GOOG -0.9%, COF -0.7%

M&A news: CF -3.9% (announced the termination of merger discussions with Yara International)

Other news: RPRX -40.6% (announces upcoming FDA meeting to be Type C meeting instead of Type B Pre-NDA meeting), CCL -3.4% (Health Care worker who may have handled Thomas Duncan's Ebola lab specimens has been isolated on CCL ship, according to reports), RCL -3% (in symp with CCL news), ANF -1.7% (following URBN guidance), AEO -1.2% (following URBN guidance), EARN -1.1% (co requested the withdrawal of its registration statement on Form S-11; intends to register on Form S-3)

Оригинал статьи: gtstocks.com/analytics-17-10-2014.html

Ближайший уровень поддержки по SPY – 182.50 уровень сопротивления – 184.00



COV продажа от 86

FAS покупка от 84

Gapping up/downs: BGG +2% after earnings, CHK +6% after asset sale; NFLX -25% EBAY -3%, DAL and GS -2% after earnings, RIO -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: HCA +4.9%, UMPQ +3.5%, BGG +2.4%, HNI +2.3%, TSM +1.8%, URI +1.7%, NTCT +1.3%, KMP +0.8%

Select Ebola related names showing strength: CMRX +6%, SRPT +2.3%, LAKE +0.6%

Select metals/mining stocks trading higher: AU +1.9%, GG +1.1%, GG +1.1%, IAG +0.8%, IAG +0.8%, PAAS +0.6%, ABX +0.5%

Other news: EGLE +120.6% (completed financial restructuring; all existing equity interests cancelled), MSO +16.8% (Martha Stewart confirms multi-year media partnership with Meredith Corporation (MDP); will have an immediate impact on Operating Income), CVV +11.5% ((reported $27.5 mln in new orders through Q3, representing an increase of ~239% in new orders from prior year),), VIMC +6.2% (announced $39.80 mln contract wins in Taiyuan City of Shanxi province), APP +6% (seeing reports that co has made an interest payment on its bonds), CHK +5.9% (announces sale of Southern Marcellus and Utica Shale assets for proceeds of $5.375 bln), ANV +5.4% (announced preliminary Q3 production and sales: 49,630 ounces of gold produced vs 52,198 in prior year), ATEA +2.4% (filed timely appeal, which will stay the suspension of trading of its common stock on NASDAQ, pending the decision by a NASDAQ hearings panel), CPA +2.4% (announced monthly traffic statistics for September 2014: System-wde passenger traffic increased 1.9% yoy)

Analyst comments: SBGL +5.5% (upgraded to Neutral from Sell at UBS), BMRN +0.2% (initiated with a Buy at Sun Trust Rbsn Humphrey)

Gapping down
Briefing note: With the S&P Futures down nearly 1% in the pre-market, many stocks are gapping lower that are not listed.

In reaction to disappointing earnings/guidance: NFLX -25%, EXTR -22.9%, BHI -11.7%, ZHNE -6.3%, MAT -4.4%, EBAY -3.3%, BX -2.9%, DAL -2.7%, GS -2.4%, PM -1.8%, BBT -1.6%, KMI -1.5%, BAX -1.5%, AXP -1.4%, FCS -0.7%, UNH -0.5%

M&A news: SHPG -1.3% (AbbVie's (ABBV) Board recommends stockholders vote against Shire transaction)

Select financial related names showing weakness: DB -5.3%, ING -5.1%, SAN -4.8%, CS -4.5%, BCS -3.9%, C -2.2%, JPM -1.9%, WFC -1.7%, BAC -1.5%

Select energy stocks trading lower: STO -6.1%, HAL -5.2%, RDS.A -4.3%, TOT -3.8%, BP -2.8%

Select EU related names showing early weakness: ALU -5.7%, UBS -4.6%, MT -4.4%, DEG -4.4%, ORAN -4.3%, ASML -4.2%, PHG -4.1%, SAP -3.6%, YY -3.3%, VOD -3.2%, NVS -2.2%

Select Momentum names of interest: GPRO -5.2%, TSLA -4.2%, TWTR -3.1%, FB -2.3%, AAPL -1.7%

Other news: INSY -8.8% (receives DEA approval to produce pharmaceutical Cannabidiol; provides update on status of cannabinoid program ), ESPR -8.6% (prices 4.25 mln shares of common stock at $20.00 per share), TTPH -6.2% ( announces proposed public offering of common stock), GWPH -6.1% (cont weakness), SHLD -4.9% (announces commencement of rights offering), JKS -4.5% (signs 200 MW PV project development agreement with Government of Shicheng County in Jiangxi Province), RIG -4.4% (provided fleet status report: total value of new contracts since the September 22, 2014 update is ~$610 mln), AEG -3.9% (announces agreement to sell its Canadian Life Insurance Business for CAD$600 mln; expected to result in a book loss of ~CAD$1.2 bln), MHR -3.7% (closes on the previously announced definitive agreement to sell certain non-core assets), CSUN -3.6% (announces CFO Mr. Yongfei Chen's resignation and appoints Mr. Shiliang Guo as acting CFO), AMZN -3% (following EBAY results), BHP -2.2% (trading in symp with RIO)

Analyst comments: CGG -8.4% (downgraded to Reduce from Neutral at Nomura), SDRL -4.5% (downgraded to Reduce from Neutral at Nomura), AKAM -3.5% (downgraded to Market Perform from Outperform at Wells Fargo), RIO -3.2% (downgraded to Market Perform at Cowen ), DIS -1.8% (downgraded to Neutral from Buy at Guggenheim).

Оригинал статьи: gtstocks.com/analytics-16-10-2014.html

Ближайший уровень поддержки по SPY – 186.00 уровень сопротивления – 188.00



NTCT смотрим на покупку, возможен откат

GILD покупка выше 96, ниже продажа

KMP продажа ниже 84

AWI покупка при удержании 46

PSX, TK, BCEI смотрим на покупку, возможен откат

AET покупка выше 74

ERX продажа ниже 64

XEC продажа ниже 104

CVX продажа ниже 109

MMP продажа ниже 71

SLB продажа ниже 88


Gapping up/down: CSX +2% and BAC +1% after earnings, CSRE +30% after merger with QCOM, Ebola names trading higher; LLTC -4% and INTC -1% after earnings, metals/miners trading lower, Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: SURG +4.7%, MTG +2.3%, CSX +1.8%, HPQ +1.8%, NHTC +1.5%, BLK +1.4%, BAC +0.7%, PNC +0.5%

M&A news: CSRE +30.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)

Select Ebola related names showing strength: APT +24.3%, LAKE +16.2%, IBIO +10%, HEB +6.3%, NLNK +6.1%, CERS +3.7%, CMRX +3.3%, SRPT +3.1%, TKMR +3%, INO +2.1%, NNVC +1.4%

Other news: ANN +8.2% (Golden Gate Capital files amended 13D with Confidentiality Agreement dated today Oct 14), NAVB +7.3% (FDA approves expanded use of Navidea's Lymphoseek for lymphatic mapping in solid tumors), GTAT +4.9% (Apple (AAPL) wants to secretly challenge GTAT bankruptcy, according to reports), MPO +4.3% (provides hedging update; 1212K barrels/day through 2Q15 at avg. ~$90/bbl), STRP +1.2% (after 18% move higher on earnings yesterday), SSRI +1.1% (analyst tour at Marigold highlights life of mine plan and exploration results), AMD +1.1% (in symp with INTC earnings), CCL +0.9% (Carnival and largest Chinese Shipyard sign Memo of Understanding aimed at growing the cruise industry in China),.

Analyst comments: PTEN +2% (initiated with a Buy at Citigroup), UNFI +1.9% (upgraded to Overweight from Neutral at Piper Jaffray), EXXI +1.5% (upgraded to Buy from Neutral at Global Hunter Securities), SWIR +1.1% (initiated with a Outperform at Northland Capital), CBS +1.1% (upgraded to Buy from Neutral at Citigroup), AMAT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), RAX +0.6% (upgraded to Outperform from Sell at Credit Agricole), HST +0.5% (upgraded to Overweight from Equal Weight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: LLTC -3.7%, KEY -2.8%, INTC -1.1%, KTCC -1.1%

M&A news: SHPG -25.9% (notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), ABBV -3.9% (Announcement of notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), QCOM -0.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)

Select EU related names showing weakness: SAN -3.5%, ALU -3.2%, BCS -2.7%, ALV -2.6%, NOK -2.5%, UBS -1.8%

Select metals/mining stocks trading lower: GFI -2.7%, RIO -2.3%, CDE -2.1%, MT -2.1%, VALE -1.8%, GOLD -1.2%, GDX -0.8%

Other news: CNET -10.3% (following 60%+ move higher yesterday), GWPH -4.9% (cont weakness), STAG -4.3% (announces public offering of 5 mln shares of common stock), NSPH -4.2% (following yesterday's 40% decline), STO -3.9% (president and CEO Helge Lund resigns), SNN -3.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), AZN -2.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), CUBE -2.2% (announces public offering of 6.5 mln common shares of beneficial interest), ESPR -1.4% (announces proposed public offering of $85 mln of common stock)

Analyst comments: RIG -2.2% (initiated with a Sell at ISI Group), OXY -0.6% (downgraded to Neutral from Outperform at Credit Suisse)

Оригинал статьи: gtstocks.com/analytics-15-10-2014.html

Ближайший уровень поддержки по SPY – 189.50 уровень сопротивления – 191.00



AVGO возможен откат вверх от 71

FFIV продажа ниже 107 выше 108 покупка

SVXY смотрим на откат вверх выше 62

SM при удержании 60,50 покупка

LRCX смотрим на покупку выше 66

CAVM следим за акцией

CPA продажа ниже 100,50

Gapping up/down: APL and ATLS +13% on M&A related news; Ebola related names trading higher, SPLK +2% on upgrade; LAD -10% and GY -3% after earnings, JCP and CLF -1% on dg's Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: MDXG +4.3%

M&A news: APL +12.8% (Targa Resources Partners and Targa Resources Corp. (TRGP) to acquire Atlas Pipeline Partners, L.P. (APL) and Atlas Energy, L.P. (ATLS)), ATLS +12.5%, CSX +9.2% (was approached for M&A deal with Canadian Pacific (CP) but CSX refused it, according to reports), TRGP +1.9%.

Select EU related names showing strength: NOK +2.3%, HSBC +2.1%, SAN +1.9%, YNDX +1.4%, RBS +1.1%, DB +0.9%

Select Ebola related stocks trading higher: IBIO +78.9% (outpacing strength seen this morning in most Ebola related names; checking around for company specific catalyst), HEB +20.6%, APT +18.7% (masks), LAKE +17.5% (masks), NLNK +4.7%, TKMR +4.1%, MLNX +2.2%, INO +1.1%, BCRX +0.7%, SIGA +0.7%

Select metals/mining stocks trading higher: MT +5%, RIO +4%, VALE +3.2%, BHP +2.7%, AU +2.3%, IAG +1.3%, GDX +1.3%, IAG +1.3%, ABX +1%

Select oil/gas related names showing strength: PBR +6.7%, SDRL +5.7%, TOT +1.6%, RIG +1.4%

Other news: DRL +66.4% (wins in Puerto Rico tax case), AHPI +7.6% (cont momentum), SHLD +4.9% (Kmart investigating payment system intrusion), AIXG +4.8% (Allianz Global Investors discloses 10.03% passive stake in 13G filing), KSU +2.6% (CSX peer), PXD +2.5% (Reliance Industries may sell PXD joint venture for $4.5 bln, according to reports), STO +1.5% (sells 15.5% share in Shah Deniz to Petronas for $2.2 bln), TASR +1.4% (announced four international orders — Australia, France, the UK, and Poland — for TASER brand next generation Smart Weapons).

Analyst comments: FOMX +8.3% (initiated with an Overweight at Barclays; initiated with a Outperform at Oppenheimer), GOLD +4.8% (upgraded to Buy from Neutral at UBS), TKAI +3.2% (initiated with an Outperform at William Blair), PRQR +3.2% (initiated with a Buy at H.C. Wainwright), SPWR +3% (upgraded to Outperform from Mkt Perform at Raymond James), SPLK +2.4% (upgraded to Outperform from Mkt Perform at William Blair), AZN +2.3% (upgraded to Buy from Hold at Jefferies), INFY +2% (upgraded to Buy form Hold at Deutsche Bank), TILE +2% (upgraded to Overweight from Equal Weight at Barclays), OUTR +1.9% (upgraded to Neutral from Sell at B. Riley & Co), SFUN +1.4% (upgraded to Buy from Hold at Deutsche Bank), TMUS +0.7% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: LAD -10.5%, GY -2.9%

M&A news: DG -1.2% (receives second request from FTC, as expected, regarding proposed acquisition of Family Dollar (FDO))

Other news: GTAT -23.5% (cont vol pre-mkt), LAD -10.5% (still checking), SFLY -7.9% (PE firm Silver Lake abandons attempt to acquire and combine Shutterly and Snapfish, according to reports), LUX -7.2% (Enrico Cavatorta to submit to the Board his resignation as CEO, also downgraded to Neutral from Buy at Citigroup), GPRO -1.8% (cont vol pre-mket), MBLY -1.2% (cautious Barrons mention)

Analyst comments: STM -2.3% (downgraded to Neutral from Overweight at JP Morgan, downgraded to Underweight from Equal-Weight at Morgan Stanley), NGD -1.8% (downgraded to Neutral from Overweight at JP Morgan), JCI -1.2% (downgraded to Outperform at RBC Capital Mkts), CLF -1% (downgraded to Neutral from Overweight at JP Morgan), JCP -1% (downgraded to Sell from Neutral at UBS), CME -0.5% (downgraded to Market Perform from Outperform at Wells Fargo)

Оригинал статьи: gtstocks.com/analytics-13-10-2014.html